EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical analysis of the impact of systematic pelvic and para-aortic lymphadenectomy on the prognosis of patients with early-stage ovarian cancer (stage IA–IIA): a propensity score matching study

Siyuan Zeng iD, Simin Xiao iD, Mingzhu Jia iD, Zhao Hu iD, Lin Changsheng iD, Lei Yu iD, Huiling Chen iD, Xue Xiao iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Siyuan Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Lymph Node Excision, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The role of systematic pelvic and para-aortic lymphadenectomy (PPAL) in completion staging surgery for early-stage (stage I-IIA) ovarian cancer (EOC) remains controversial. This study evaluates the impact of PPAL on the prognosis of EOC patients. METHODS: A retrospective cohort study was conducted using data from the Surveillance, Epidemiology, and End Results database. Patients with EOC (stage I-IIA) were included. Propensity score matching (PSM) was used at a 1:1 ratio based on age, marital status, race, tumor grade, histological type, FIGO stage, and postoperative adjuvant therapy. Post-matching overall survival (OS) and cancer-specific survival (CSS) were compared between the systematic PPAL group (pathological staging) and the non-lymphadenectomy group (clinical staging). RESULTS: After PSM, no significant differences were observed in OS (p=0.140) and CSS (p=0.066) between the two groups. Subgroup analysis showed that for tumor grade III patients, the pathological staging group had significantly higher OS (p=0.028) and CSS (p=0.010) than the clinical staging group. Multivariate Cox regression indicated that tumor grade III was an independent prognostic factor for OS (p=0.006) and CSS (p=0.020). CONCLUSION: Systematic PPAL does not significantly improve survival in EOC patients. However, for tumor grade III patients, the pathological staging group demonstrates significantly better prognosis, offering a more personalized alternative to routine staging surgery, which requires further validation through prospective trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsLymph Node ExcisionCarcinoma, Ovarian EpithelialHumansFemalePropensity ScoreRetrospective StudiesMiddle AgedNeoplasm StagingPrognosisSEER ProgramAgedPelvisAdult

Stichwörter der Autor:innen

LymphadenectomyOvarian NeoplasmsPrognosisPropensity ScoreRetrospective Studies

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China.
  • Department of Radiology, Xin Du Hospital of Traditional Chinese Medicine, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China. xiaoxue19811454@163.com.

ORCID-Profile: Siyuan Zeng, Simin Xiao, Mingzhu Jia, Zhao Hu, Lin Changsheng, Lei Yu, Huiling Chen, Xue Xiao

Zitieren

APA

Zeng, S., Xiao, S., Jia, M., Hu, Z., Changsheng, L., Yu, L., Chen, H., & Xiao, X. (2026). Clinical analysis of the impact of systematic pelvic and para-aortic lymphadenectomy on the prognosis of patients with early-stage ovarian cancer (stage IA–IIA): a propensity score matching study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e5

Vancouver

Zeng S, Xiao S, Jia M, Hu Z, Changsheng L, Yu L, et al. Clinical analysis of the impact of systematic pelvic and para-aortic lymphadenectomy on the prognosis of patients with early-stage ovarian cancer (stage IA–IIA): a propensity score matching study. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e5

BibTeX
@article{Zeng2026,
  author = {Zeng, Siyuan and Xiao, Simin and Jia, Mingzhu and Hu, Zhao and Changsheng, Lin and Yu, Lei and Chen, Huiling and Xiao, Xue},
  title = {Clinical analysis of the impact of systematic pelvic and para-aortic lymphadenectomy on the prognosis of patients with early-stage ovarian cancer (stage IA–IIA): a propensity score matching study},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e5}
}
Kostenlos starten →